Company latest

News and press

September 2009

New Product Launch – Ondansetron Oral Liquid…

Focus is pleased to announce the launch of Ondansetron Oral Liquid 4mg per 5ml to the market…

Full story

Corporate objectives

  • Focus delivers new niche generic products to the UK market to generate sustainable income streams that can be reinvested in new product development
  • Focus aims to maintain its double digit growth through the introduction of at least five new products each year
  • Focus dedicates almost half its annual expenditure year on year to developing new generic products for the UK product
  • Focus aims to give its customers choices and alternatives in the prescription only medicines market